| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 135.44B | 141.03B | 134.77B | 126.91B | 131.61B | 123.96B |
| Gross Profit | 20.69B | 21.62B | 19.43B | 17.84B | 17.98B | 16.46B |
| EBITDA | 8.63B | 9.10B | 8.87B | 8.27B | 8.98B | 7.81B |
| Net Income | 4.74B | 5.11B | 4.89B | 4.67B | 4.97B | 4.25B |
Balance Sheet | ||||||
| Total Assets | 119.76B | 127.64B | 121.33B | 127.69B | 122.81B | 120.56B |
| Cash, Cash Equivalents and Short-Term Investments | 20.76B | 22.96B | 21.80B | 25.05B | 23.87B | 27.55B |
| Total Debt | 8.38B | 4.39B | 4.76B | 4.73B | 5.33B | 5.75B |
| Total Liabilities | 33.33B | 35.74B | 35.10B | 39.50B | 36.48B | 37.25B |
| Stockholders Equity | 86.43B | 91.90B | 86.23B | 88.19B | 86.32B | 83.31B |
Cash Flow | ||||||
| Free Cash Flow | 462.50M | 1.48B | 2.06B | 3.36B | 620.00M | -10.00M |
| Operating Cash Flow | 849.50M | 4.30B | 4.47B | 5.02B | 2.12B | 3.07B |
| Investing Cash Flow | 987.50M | -479.00M | 3.27B | -2.43B | 46.00M | -3.77B |
| Financing Cash Flow | -2.61B | -2.79B | -6.32B | -4.89B | -2.49B | -1.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥43.81B | 9.16 | ― | 3.87% | 1.79% | -12.61% | |
77 Outperform | ¥308.80B | 21.45 | ― | 1.68% | 8.46% | 26.64% | |
74 Outperform | ¥74.62B | 14.81 | ― | 3.17% | 4.65% | 5.17% | |
73 Outperform | ¥154.63B | 9.94 | ― | 1.72% | 46.71% | 77.52% | |
72 Outperform | ¥35.03B | 10.37 | ― | 4.05% | 5.23% | 0.86% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥146.79B | 9.32 | ― | 2.42% | 8.46% | -3.62% |